Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
The Vanguard Group reported a 5.54% stake in Eledon Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.54% stake in Eledon Pharmaceuticals, Inc., 3,318,383 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 5.54%
- Shares
- 3,318,383
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.54% | 3,318,383 |
Source
Related
- Eledon Pharmaceuticals, Inc.
- The Vanguard Group
- Eledon Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Gros David-Alexandre C · Aug 4, 2026
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026